CV

Education

• B.S. in Mathematics, option in Statistics, CSULB, 2017
• Ph.D in Biostatistics, UCLA (in progress)

Academic Work Experience

• 01/2019 - Present: Graduate Research Assistant
  • UCLA
• 09/2018 - 06/2019: Teaching Assistant
  • UCLA
  • Led lab sections and graded homework for an introductory biostatistics course
• 10/2017 - 01/2018: Research Assistant
  • CSULB
  • Created an Artificial Neural Network to predict the spread of wildfires
  • Supervisor: Professor Eun Heui Kim

Industry Work Experience

• 08/2018 - 02/2021: Technical Professional
  • Northrop Grumman
• 01/2018 - 08/2018: System Engineer
  • Northrop Grumman
• 05/2017 - 07/2017: Systems Engineering Intern
  • Northrop Grumman

Publications

Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation

Kishan, A. U., Marco, N., Schulz-Jaavall, M. B., Steinberg, M. L., Tran, P. T., Juarez, J. E., ... & Weidhaas, J. B. (2022). Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation. Radiotherapy and Oncology, 167, 226-232.

Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy

Weidhaas, J., Marco, N., Scheffler, A. W., Kalbasi, A., Wilenius, K., Rietdorf, E., ... & Telesca, D. (2022). Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy. Journal for immunotherapy of cancer, 10(2).

Viral burden and clearance in asymptomatic COVID-19 Patients

Gunatilaka, A. B., Marco, N., Read, G. H., Sweeney, M., Regan, G., Tsang, C., ... & Weidhaas, J. B. (2022, May). Viral burden and clearance in asymptomatic COVID-19 Patients. In Open forum infectious diseases (Vol. 9, No. 5, p. ofac126). US: Oxford University Press.

Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial

Kishan, A.U., Marco, N., Ma, T.M., Steinberg, M.L., Sachdeva, A., Cao, M., Ballas, L.K., Rietdorf, E., Telesca, D. and Weidhaas, J.B., 2023. Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial. Clinical and Translational Radiation Oncology, 39, p.100594.

Early findings from the GARUDA trial: The impact of a genetic signature of late radiation toxicity on prostate cancer treatment decision making.

Weidhaas, J.B., Marco, N., Steinberg, M.L., Lee, A., Xiang, M., Valle, L.F., Casado, M., Stube, A., Telesca, D. and Kishan, A.U., 2023. Early findings from the GARUDA trial: The impact of a genetic signature of late radiation toxicity on prostate cancer treatment decision making.

Functional Mixed Membership Models

Marco, N., Şentürk, D., Jeste, S., DiStefano, C., Dickinson, A. and Telesca, D., 2024. Functional Mixed Membership Models. Journal of Computational and Graphical Statistics, (just-accepted), pp.1-18.

Flexible Regularized Estimation in High-Dimensional Mixed Membership Models

Marco, N., Şentürk, D., Jeste, S., DiStefano, C.C., Dickinson, A. and Telesca, D., 2024. Flexible Regularized Estimation in High-Dimensional Mixed Membership Models. Computational Statistics & Data Analysis, p.107931.

Talks

Bayesian Functional Partial Membership Models

June 24, 2021

Talk at Joint Statistical Meetings,